Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A
Early emicizumab (Hemlibra) prophylaxis alone prevented clinically relevant bleeds in patients with newly diagnosed acquired hemophilia A, while avoiding the infectious complications of immunosuppressive therapy in this vulnerable population, a phase II study showed. Over 12 weeks of therapy, a high-dose regimen of the factor VIIIa mimetic antibody yielded a low mean breakthrough bleeding rate […]
Opinion | ‘Medically Relevant to Saving the Life of Your Patient’: What We Heard This Week
“It’s medically relevant to saving the life of your patient.” — Paul Nestadt, MD, of the Johns Hopkins Anxiety Disorders Clinic in Baltimore, about why clinicians should ask patients about gun access in the home. “If you don’t have insurance, how are you getting that?” — Capt. Christina Bell, MD, of the Womack Army Medical […]